145
Views
0
CrossRef citations to date
0
Altmetric
Short Reports

Slow progression of amyotrophic lateral sclerosis in a Chinese patient carrying SOD1 p.S135T mutation

, ORCID Icon, , &
Pages 143-145 | Received 10 Feb 2021, Accepted 29 Mar 2021, Published online: 16 Apr 2021

References

  • Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
  • Cook C, Petrucelli L. Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron 2019;101:1057–69.
  • Wei Q, Chen X, Chen Y, Ou R, Cao B, Hou Y, et al. Unique characteristics of the genetics epidemiology of amyotrophic lateral sclerosis in China. Sci China Life Sci. 2019;62:517–25.
  • Richards S, ACMG Laboratory Quality Assurance Committee, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody W, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
  • Akimoto C, Morita M, Atsuta N, Sobue G, Nakano I. High-resolution melting (HRM) analysis of the Cu/Zn superoxide dismutase (SOD1) gene in Japanese sporadic amyotrophic lateral sclerosis (SALS) patients. Neurol Res Int. 2011;2011:165415.
  • Cui F, Cai W, Wang Z, Ren Y, Li M, Sun Z, et al. New mutation in the SOD1 (copper/zinc superoxide dismutase-1) gene in a Chinese amyotrophic lateral sclerosis (ALS) patient. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:635–7.
  • Watanabe M, Aoki M, Abe K, Shoji M, Iizuka T, Ikeda Y, et al. A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutat. 1997;9:69–71.
  • Marucci G, Morandi L, Bartolomei I, Salvi F, Pession A, Righi A, et al. Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome. Neuromuscul Disord. 2007;17:673–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.